Capital Research Global Investors’s Guardant Health GH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2,301,472
| Closed | -$62.3M | – | 420 |
|
2023
Q4 | $62.3M | Hold |
2,301,472
| – | – | 0.02% | 308 |
|
2023
Q3 | $68.2M | Buy |
2,301,472
+611,191
| +36% | +$18.1M | 0.02% | 303 |
|
2023
Q2 | $60.5M | Buy |
1,690,281
+690,281
| +69% | +$24.7M | 0.02% | 318 |
|
2023
Q1 | $23.4M | Sell |
1,000,000
-1,001,782
| -50% | -$23.5M | 0.01% | 366 |
|
2022
Q4 | $54.4M | Sell |
2,001,782
-148,722
| -7% | -$4.05M | 0.02% | 320 |
|
2022
Q3 | $116M | Buy |
2,150,504
+1,171
| +0.1% | +$63K | 0.04% | 253 |
|
2022
Q2 | $86.7M | Sell |
2,149,333
-1,860,172
| -46% | -$75M | 0.03% | 290 |
|
2022
Q1 | $266M | Sell |
4,009,505
-3,918,197
| -49% | -$260M | 0.07% | 212 |
|
2021
Q4 | $793M | Buy |
7,927,702
+2,640,910
| +50% | +$264M | 0.18% | 122 |
|
2021
Q3 | $661M | Buy |
5,286,792
+3,128,063
| +145% | +$391M | 0.15% | 138 |
|
2021
Q2 | $268M | Buy |
2,158,729
+120,975
| +6% | +$15M | 0.06% | 220 |
|
2021
Q1 | $311M | Buy |
2,037,754
+4,991
| +0.2% | +$762K | 0.08% | 209 |
|
2020
Q4 | $262M | Buy |
2,032,763
+40,093
| +2% | +$5.17M | 0.07% | 217 |
|
2020
Q3 | $223M | Buy |
1,992,670
+39,650
| +2% | +$4.43M | 0.07% | 206 |
|
2020
Q2 | $158M | Buy |
1,953,020
+800,887
| +70% | +$65M | 0.05% | 229 |
|
2020
Q1 | $80.2M | Buy |
1,152,133
+28,921
| +3% | +$2.01M | 0.03% | 256 |
|
2019
Q4 | $87.8M | Buy |
1,123,212
+44,061
| +4% | +$3.44M | 0.03% | 274 |
|
2019
Q3 | $68.9M | Buy |
1,079,151
+458,852
| +74% | +$29.3M | 0.02% | 296 |
|
2019
Q2 | $53.6M | Buy |
+620,299
| New | +$53.6M | 0.02% | 309 |
|